VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ELDN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ELDNEledon Pharmaceuticals, Inc.
$3.88$233M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksELDNQuarterly Financials

Eledon Pharmaceuticals, Inc. (ELDN) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Eledon Pharmaceuticals, Inc. (ELDN) quarterly income statement — complete revenue, gross profit & net income history

ELDN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit00000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses21.18M21.48M19.07M24.73M17.96M24.7M20.51M14.5M10.87M10.34M11.2M10.35M11.11M58.69M10.6M9.28M9.86M9.38M10.51M7.97M
OpEx % of Revenue--------------------
Selling, General & Admin3.98M3.99M4.1M4.46M4.43M6.77M3.99M4.4M3.46M3.27M3.27M3.15M3M2.79M3.15M3.54M3.22M3.2M2.85M3.73M
SG&A % of Revenue--------------------
Research & Development17.2M17.49M14.97M20.28M13.53M17.93M16.52M10.11M7.41M7.07M7.93M7.2M8.11M7.25M7.45M5.74M6.63M6.18M7.66M4.24M
R&D % of Revenue--------------------
Other Operating Expenses00000000000001000K000000
Operating Income-21.18M-21.48M-19.07M-24.73M-17.96M-24.7M-20.51M-14.5M-10.87M-10.34M-11.2M-10.35M-11.11M-58.69M-10.6M-9.28M-9.86M-9.38M-10.51M-7.97M
Operating Margin %--------------------
Operating Income Growth %-17.91%13.01%7.02%-70.55%-65.28%-138.89%-83.16%-40.06%2.17%82.38%-5.66%-11.54%-12.69%-525.34%-0.88%-16.46%-9.48%-47.84%-70.88%-207.64%
EBITDA-21.18M-21.4M-19.07M-24.73M-17.96M-24.61M-20.43M-14.4M-10.77M-10.24M-11.1M-10.26M-11.02M-58.59M-10.51M-9.19M-9.77M-9.32M-10.46M-7.93M
EBITDA Margin %--------------------
EBITDA Growth %-17.91%13.02%6.66%-71.7%-66.73%-140.22%-84%-40.4%2.21%82.52%-5.7%-11.66%-12.82%-528.43%-0.41%-15.92%-9.01%-47.93%-71.45%-211.47%
D&A (Non-Cash Add-back)081K00088K79K97K95K94K94K94K92K93K93K94K93K61K44K44K
EBIT-21.18M-21.48M-19.07M-24.73M-17.96M-24.7M-20.51M-14.5M-10.87M-10.34M-11.2M-10.35M-11.11M-10.04M-10.6M-9.28M-9.86M-9.38M-10.51M-7.97M
Net Interest Income000000000-338K000000-5K000
Interest Income00000000000000000000
Interest Expense000000000338K0000005K000
Other Income/Expense-17.84M11.07M1.61M13.52M11.47M-19.49M97.48M-30.41M-12.76M712K1.29M-55.41M338K304K127K36K-5K03K-1K
Pretax Income-39.02M-10.41M-17.46M-11.22M-6.5M-44.19M76.97M-44.91M-23.63M-9.63M-9.91M-65.76M-10.77M-58.38M-10.47M-9.25M-9.86M-9.38M-10.5M-7.97M
Pretax Margin %--------------------
Income Tax035K000431K00000000000-579K-686K-588K
Effective Tax Rate %0%-0.34%0%0%0%-0.98%0%0%0%0%0%0%0%0%0%0%0%6.17%6.53%7.38%
Net Income-39.02M-10.45M-17.46M-11.22M-6.5M-44.62M76.97M-44.91M-23.63M-9.63M-9.91M-65.76M-10.77M-58.38M-10.47M-9.25M-9.86M-8.81M-9.82M-7.38M
Net Margin %--------------------
Net Income Growth %-500.85%76.59%-122.68%75.02%72.51%-363.51%877.01%31.71%-119.37%83.51%5.4%-611.15%-9.21%-563%-6.66%-25.23%-16.06%-49.15%-59.78%-185.54%
Net Income (Continuing)-39.02M-10.45M-17.46M-11.22M-6.5M-44.62M76.97M-44.91M-23.63M-9.63M-9.91M-65.76M-10.77M-58.38M-10.47M-9.25M-9.86M-8.81M-9.82M-7.38M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.35-0.14-0.23-0.15-0.08-0.75-0.32-1.06-0.79-3.55-0.33-2.74-0.75-4.24-0.73-0.65-0.69-0.62-0.66-0.50
EPS Growth %-315.68%81.33%28.13%85.85%89.34%78.87%3.03%61.31%-5.33%16.27%54.79%-321.54%-8.7%-583.87%-10.61%-30%-21.05%-58.97%88.02%81.75%
EPS (Basic)-0.35-0.14-0.23-0.15-0.08-0.751.05-1.06-0.79-3.55-0.33-2.74-0.75-4.24-0.73-0.65-0.69-0.62-0.66-0.50
Diluted Shares Outstanding112.42M75.43M77.16M77.16M77.13M59.79M55.48M42.28M29.99M24.21M29.97M24.01M14.29M13.78M14.27M14.27M14.33M14.31M14.82M14.82M
Basic Shares Outstanding112.42M75.43M77.16M77.16M77.13M59.79M51.95M42.28M29.99M24.21M29.97M24.01M14.29M13.78M14.27M14.27M14.33M14.31M14.82M14.82M
Dividend Payout Ratio--------------------